Trial Outcomes & Findings for Positron Emission Mammography (PEM) Biopsy Accessory for the Diagnosis of Breast Cancer (NCT NCT00981812)

NCT ID: NCT00981812

Last Updated: 2016-04-04

Results Overview

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

20 participants

Primary outcome timeframe

At time of biopsy

Results posted on

2016-04-04

Participant Flow

Recruited from 02/2010 to 06/2011 from University of Cincinnati Medical Center, Radiology Department, Breast Imaging.

Participant milestones

Participant milestones
Measure
PEM Breast Biopsy
PEM Breast Biopsy: Breast biopsy using PEM guidance and Stereo Navigator software
Overall Study
STARTED
20
Overall Study
COMPLETED
20
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Positron Emission Mammography (PEM) Biopsy Accessory for the Diagnosis of Breast Cancer

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Primary
n=20 Participants
Women 25 years or older with a highly suspicious finding for possible breast cancer on mammography and/or ultrasound, who are to be scheduled for percutaneous breast biopsy.
Age, Categorical
<=18 years
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
17 Participants
n=5 Participants
Age, Categorical
>=65 years
3 Participants
n=5 Participants
Sex: Female, Male
Female
20 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants

PRIMARY outcome

Timeframe: At time of biopsy

Outcome measures

Outcome measures
Measure
Lesions Visualized Using Positron Emission Mammography (PEM)
n=20 Participants
Total lesions visualized using positron emission mammography.
Feasibility That Breast Biopsy Can be Performed Using PEM and Stereo Navigator Software After Diagnostic PEM on the Same Day.
Index Lesioins
22 Breast Lesions
Feasibility That Breast Biopsy Can be Performed Using PEM and Stereo Navigator Software After Diagnostic PEM on the Same Day.
Index Lesions Visualized at PEM
21 Breast Lesions
Feasibility That Breast Biopsy Can be Performed Using PEM and Stereo Navigator Software After Diagnostic PEM on the Same Day.
Additional Lesions seen only at PEM
6 Breast Lesions
Feasibility That Breast Biopsy Can be Performed Using PEM and Stereo Navigator Software After Diagnostic PEM on the Same Day.
Lesions technically adequate for targeting
26 Breast Lesions
Feasibility That Breast Biopsy Can be Performed Using PEM and Stereo Navigator Software After Diagnostic PEM on the Same Day.
Number of Lesions Biopsied
24 Breast Lesions

Adverse Events

PEM Breast Biopsy

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Mary Mahoney, MD

University of Cincinnati Medical Center

Phone: 513-584-4396

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place